📰 Cell Reprogramming News
Cell Reprogramming News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cell Reprogramming. Real-time updates on events, politics, business and more.
April 19, 2024
InSphero presents the 3D InSight™ Oncology Platform to assess the efficacy of tumor-dendritic cell reprogramming
October 31, 2023
As of spring 2023, NASA has invested greater than $60M in more than twenty In Space Production Applications (InSPA) awards to U.S. entities seeking to
May 27, 2023
The widespread Transfection Technologies Market report presents crucial information about the elements that are impacting and driving the sales of the Transfection Technologies market. In this market report, a methodical SWOT analysis & investment analysis is performed which forecasts forthcoming opportunities for t...
December 2, 2022
EQS-News: Enlivex Therapeutics, Ltd. First Patients Dosed in Phase I/II Trial of Enlivex’s Off-the-Shelf Cell Therapy Candidate, AllocetraTM 02.12.2022 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. On November 13, Enlivex (NASDAQ: ENLV) announced that th...
June 10, 2022
Five area businesses have received grants to help them commercialize their products through SBIR Advance’s latest funding round.
March 8, 2022
A biology major, professional baker and former taekwondo athlete, Jordan Kramer (C’22) started studying cancer at 16, continuing her research while at Georgetown and now at Oxford next fall.
February 3, 2022
New research can help predict a cell’s path over time, such as what type of cell it will become, in normal settings or under genetic perturbations. The work is led by Jonathan Weissman, MIT professor and Whitehead Institute member, and collaborators.